AI Verdict
GEHC has stronger fundamentals based on our AI analysis.
GELS vs GEHC Fundamental Comparison
| Metric | GELS | GEHC |
|---|---|---|
| Revenue | N/A | $20.6B |
| Net Income | N/A | $2.1B |
| Net Margin | N/A | 10.1% |
| ROE | N/A | 20.1% |
| ROA | N/A | 5.6% |
| Current Ratio | N/A | 1.37x |
| Debt/Equity | N/A | 0.96x |
| EPS | N/A | $4.55 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GELS vs GEHC: Frequently Asked Questions
Is GELS or GEHC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GEHC has stronger fundamentals. GELS is rated SELL (95% confidence) while GEHC is rated HOLD (62% confidence). This is not investment advice.
How does GELS compare to GEHC fundamentally?
Gelteq Ltd has ROE of N/A vs GE HealthCare Technologies Inc.'s 20.1%. Net margins are N/A vs 10.1% respectively.
Which stock pays higher dividends, GELS or GEHC?
GELS has a dividend yield of N/A or no dividend while GEHC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GELS or GEHC for long term?
For long-term investing, consider that GELS has SELL rating with 95% confidence, while GEHC has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GELS vs GEHC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GELS vs GEHC, the AI consensus favors GEHC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.